Welcome to the e-CCO Library!

P226: Dietary patterns differ in the newly diagnosed IBD cohort with ethnicity as a key confounding variable, a case control study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Dyall, L.(1)*;Kyle, J.(2);Misra, R.(3);Clark, H.(4);Limdi, J.(5);Cooney, R.(6);Brookes, M.(7);Fogden, E.(8);Pattni, S.(9);Sharma, N.(10);Iqbal, T.(6);Munkholm, P.(11);Burisch, J.(11);Arebi, N.(3);
Created: Friday, 14 July 2023, 10:48 AM
P226: Does faecal Calprotectin help differentiate inflammatory from fibrous stenosis in Crohn’s disease?
Year: 2021
Source: ECCO'21 Virtual
Authors: Ben Farhat, F.(1);Sabbah, M.(2);Ben Abid, M.(3);Bibani, N.(1);Bellil, N.(1);Aoun, K.(4);Bouratbine, A.(5);Gargouri, D.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P226: Nuclear magnetic resonance spectroscopy measure of protein glycosylation is a biomarker of activity and metabolic complications in Inflammatory Bowel Disease.
Year: 2022
Source: ECCO'22
Authors: García Mateo, S.(1,2);Martínez-Dominguez, S.J.(1,2);Aso Gonzalvo, M.C.(1);Refaie, E.(3);Gallego Llera , B.(1);Alfambra Cabrejas , E.(1);Sanz, B.(4);Amigó Grau, N.(5);Ribalta, J.(6,7);Martínez-Micaelo, N.(8);Gargallo-Puyuelo, C.J.(1,2);Gomollón, F.(1,2,9);
Created: Friday, 11 February 2022, 3:52 PM
P226: Relevant factors and significant endoscopic findings for detecting colitis-associated neoplasms using pancolonic narrow band imaging surveillance colonoscopy in patients with ulcerative colitis: A sub-analysis of prospective randomised trial
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Watanabe1*, R. Kawano2, M. Nishishita3, F. Shimamoto4, T. Fukuchi5, M. Esaki6, Y. Okamoto6, Y. Maehata6, S. Oka7, S. Nishiyama7, S. Fujii8, F. Hirai9, T. Matsui9, K. Kakimoto10, T. Okada10, T. Inoue11, N. Hida12, R. Nozaki13, T. Sakurai14, H. Kashida14, K. Takeuchi15, N. Ohmiya16, M. Saruta17, S. Saito18, Y. Saito19, S. Nakamura12, S. Tanaka7, Y. Suzuki15, Y. Ajioka20, H. Tajiri17

Created: Thursday, 21 February 2019, 9:14 AM
P226: Systematic review with meta-analysis of individual data: impact of cut-off values on the performance of faecal calprotectin to detect endoscopic recurrence after intestinal resection in patients with Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Kirchgesner1, G. Boschetti2, A. Buisson3, T. Yamamoto4, E. Domenech5, S. Nancey2, L. Peyrin-Biroulet6, M. Uzzan*7

Created: Friday, 22 February 2019, 9:41 AM
P226: The first validated post-operative endoscopic Crohn’s disease index: the POCER index— identification of key endoscopic prognostic factors
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. De Cruz*1, 2, M. Kamm1, A. Hamilton2, K. Ritchie3, A. Gorelik2, D. Liew2, I. Lawrance4, J. Andrews5, P. Bampton6, P. Gibson7, M. Sparrow7, R. Leong8, T. Florin9, R. Gearry10, G. Radford-Smith9, F. Macrae2, H. Debinski11, W. Selby12, I. Kronborg1, M. Johnston13, R. Woods14, R. Elliott3, S. Bell3, S. Brown3, W. Connell3, P. Desmond3

Created: Friday, 22 February 2019, 9:49 AM
P227 Defining faecal calprotectin thresholds to predict endoscopic and histological healing in ulcerative colitis (UC) by using advanced optical enhancement techniques
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Cannatelli1,2, D. Zardo3, O. Nardone1, A. Bazarova4, U. Shivaji1,5, S.C.L. Smith1,5, S. Ghosh1,5,6, M. Iacucci1,5,6

Created: Thursday, 30 January 2020, 10:12 AM
P227: A web-based telemanagement system for patients with complex Inflammatory Bowel Disease (TECCU): Results of a randomised controlled clinical trial
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Aguas1,2,3, J. Del Hoyo1*, R. Faubel4,5, D. Muñoz1, D. Domínguez6, G. Bastida1,2, B. Navarro1, G. Cordon1, A. Barrios1, B. Valdivieso3,7, M. Correcher8, P. Nos1,2,3

Created: Thursday, 21 February 2019, 9:14 AM
P227: Association between pouchitis and faecal calprotectin following restorative proctocolectomy in patients with ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Fujimori*1,2, M. Uchino2, H. Ikeuchi2, T. Masaki1

Created: Friday, 22 February 2019, 9:41 AM
P227: Faecal calprotectin reductions in patients achieving mucosal healing with vedolizumab induction therapy in GEMINI 1
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. D. Lewis*1, W. Reinisch2, B. Bressler3, A. Parikh4, H. Yang5, M. Rosario5, A. Roseth6, S. Danese7, B. G. Feagan8, B. E. Sands9, P. Ginsburg10, T. Dassopoulos11, J. Xu5, T. Wyant5

Created: Friday, 22 February 2019, 9:49 AM
P227: High prevalence of mental health illness in IBD patients with high caregiver burden in the developing world: An analysis of risk factors from the IBD Emerging Nations Consortium (IBD-ENC)
Year: 2022
Source: ECCO'22
Authors: Banerjee, R.(1);Pal, P.(1);Hilmi, I.(2);Rahman, M.(3);Aye, T.T.(4);Joshi, N.(5);Ghoshal, U.(6);Alavinejad, P.(7);Peddi, K.(8);Mudigonda, S.(1);
Created: Friday, 11 February 2022, 3:52 PM
P227: Outcomes of anti-TNF versus Vedolizumab therapy for ulcerative colitis: the Leeds experience
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lenti M.V.*1, Johnston A.1, O'Connor A.2, Selinger C.1, Ford A.C.3, Hamlin P.J.1

Created: Wednesday, 20 February 2019, 10:36 AM
P227: Patient experiences in ulcerative colitis: conceptual model and review of patient-reported outcome measures
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kim, C.(1)*;Brown, F.L.(2);Burk, C.(3);Anatchkova, M.(4);Sargalo, N.(2);Kaushik, A.(1);
Created: Friday, 14 July 2023, 10:48 AM
P227: Timing of acute severe colitis in the course of an inflammatory bowel disease: is it a prognostic factor?
Year: 2021
Source: ECCO'21 Virtual
Authors: Sahar, N.(1);Dahmani, W.(1);Nour, E.(1);Aya, H.(1);Wafa, B.A.(1);Aida, B.S.(1);Ahlem, B.(1);Mehdi, K.(1);Hanene, J.(1);Ali, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P228 Cytomegalovirus Infection: is it a cause of flare-up in inflammatory bowel diseases?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Busacca1, R. Mascaretti1, L. Carrozza1, L. Guida1, S. De Grazia2, S. Peralta1, V. Calvaruso1, M. Cappello1

Created: Thursday, 30 January 2020, 10:12 AM
P228: Appendiceal Orifice Inflammation Is Associated with Lower Rate of Complete Endoscopic Remission in Patients with Ulcerative Colitis
Year: 2022
Source: ECCO'22
Authors: Oh, C.K.(1);Lee, H.H.(2);Kim, J.S.(3);Lee, B.I.(1);Cho, Y.S.(1);
Created: Friday, 11 February 2022, 3:52 PM
P228: Machine learning models utilizing simple laboratory tests may assess endoscopic activity in ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kempinski, R.(1)*;Kraszewski, S.(2);Nizioł, P.(3);Neubauer, K.(4);
Created: Friday, 14 July 2023, 10:48 AM
P228: Prehabilitation strategies prior to ileocolonic resection in Crohn’s disease in a prospective cohort study: a missed window of opportunity?
Year: 2021
Source: ECCO'21 Virtual
Authors: Ruiterkamp, M.(1);Arkenbosch, J.(1);van Ruler, O.(2);van der Marel, S.(3);van Dongen, K.(4);Maljaars, P.W.J.(5);Hoentjen, F.(6);West, R.(7);Jharap, B.(8);Dijkstra, G.(9);Campmans-Kuijpers, M.(10);Jansen, S.(11);Romberg-Camps, M.(12);Stassen, L.(13);van der Woude, C.J.(1);de Vries, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P228: Preliminary Evaluation of a new immunofluorescence mosaic assay for inflammatory bowel disease diagnosis: a pilot study in Udine
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Fabris1,2, F. Meroi3, A. Cifu'2, E. Castagnaviz3, F. Curcio1,2, G. Terrosu4,5, G. Scardino3, S. F. Vadalà di Prampero3, M. Marino*3

Created: Friday, 22 February 2019, 9:41 AM
P228: Prevalence and risk factor of CMV infection among hospitalized patients with ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Song G.A., Baek D.H., Han I.S., Han S.Y.

Created: Wednesday, 20 February 2019, 10:36 AM